There were 352 press releases posted in the last 24 hours and 431,743 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Consistent safety findings and durable activity with filgotinib treatment of rheumatoid arthritis patients up to week 84 in DARWIN 3 study

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image